| Year |
Citation |
Score |
| 2019 |
Gutkin DW, Shurin MR, El Azher MA, Shurin GV, Velikokhatnaya L, Prosser D, Shin N, Modugno F, Stemmer P, Elishaev E, Lokshin A. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary. Cancer Biomarkers : Section a of Disease Markers. PMID 31658047 DOI: 10.3233/Cbm-190528 |
0.399 |
|
| 2019 |
Tarney CM, Wang G, Bateman NW, Conrads KA, Zhou M, Hood BL, Loffredo J, Tian C, Darcy KM, Hamilton CA, Casablanca Y, Lokshin A, Conrads TP, Maxwell GL. Biomarker Panel for Early Detection of Endometrial Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. American Journal of Obstetrics and Gynecology. PMID 31279844 DOI: 10.1016/J.Ajog.2019.06.005 |
0.492 |
|
| 2019 |
Guo J, Yang WL, Pak D, Celestino J, Lu KH, Ning J, Lokshin AE, Cheng Z, Lu Z, Bast RC. Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer. Cancers. 11. PMID 31035430 DOI: 10.3390/Cancers11050596 |
0.45 |
|
| 2019 |
Barton JK, Lokshin AE, Fishman DA, Black JF. Abstract AP07: PROTEIN AND IMAGING MARKERS FOR EARLY DETECTION OF EPITHELIAL OVARIAN CANCER Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Ap07 |
0.459 |
|
| 2019 |
Guo J, Yang W, Celestino J, Lu K, Lokshin AE, Lu Z, Bast RC. Abstract 912: Macrophage inhibitory factor (MIF), osteopontin (OPN) and anti-interleukin-8 (IL-8) autoantibodies (AAb) complement CA125 for detection of early-stage ovarian cancer Cancer Research. 79: 912-912. DOI: 10.1158/1538-7445.Am2019-912 |
0.46 |
|
| 2019 |
Tarney C, Wang G, Bateman N, Conrads K, Zhou M, Hood B, Loffredo J, Tian C, Darcy K, Lokshin A, Hamilton C, Casablanca Y, Maxwell G, Conrads T. Biomarker panel for early detection of endometrial cancer in the prostate, lung, colorectal, and ovarian cancer screening trial Gynecologic Oncology. 154: 42-43. DOI: 10.1016/J.YGYNO.2019.04.102 |
0.367 |
|
| 2018 |
Linkov F, Goughnour SL, Adambekov S, Lokshin A, Kelley JL, Sukumvanich P, Comerci JT, Marra KG, Kokai LE, Rubin JP, Vlad AM, Philips BJ, Edwards RP. Inflammatory biomarker in adipose stem cells of women with endometrial cancer. Biomarkers in Medicine. PMID 30043637 DOI: 10.2217/Bmm-2017-0355 |
0.382 |
|
| 2018 |
Lokshin AE, Azher MAE, Velikokhatnaya L, Prosser D. Abstract 5142: Elevated glycolysis in pre-malignant ovarian cancer Cancer Research. 78: 5142-5142. DOI: 10.1158/1538-7445.Am2018-5142 |
0.49 |
|
| 2018 |
Malykh AG, Malek A, Lokshin A, Evtushenko V. Abstract 1618: Simultaneous isolation of exosomes and cfDNA from liquid biopsies using universal kit based on SubX-MatrixTM technology Cancer Research. 78: 1618-1618. DOI: 10.1158/1538-7445.Am2018-1618 |
0.351 |
|
| 2017 |
Linkov F, Goughnour SL, Ma T, Xu Z, Edwards RP, Lokshin AE, Ramanathan RC, Hamad GG, McCloskey C, Bovbjerg DH. Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight loss. Gynecologic Oncology. PMID 28797697 DOI: 10.1016/J.Ygyno.2017.07.144 |
0.376 |
|
| 2017 |
Al Efishat MA, Attiyeh MF, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CF, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, et al. Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas. Annals of Surgery. PMID 28700444 DOI: 10.1097/Sla.0000000000002421 |
0.313 |
|
| 2017 |
Linkov F, Goughnour SL, Edwards RP, Lokshin A, Ramanathan RC, Hamad GG, McCloskey C, Bovbjerg DH. Endometrial cancer associated biomarkers in bariatric surgery candidates: exploration of racial differences. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. PMID 28256392 DOI: 10.1016/J.Soard.2017.01.024 |
0.433 |
|
| 2016 |
Kim SH, Hahm ER, Arlotti JA, Samanta SK, Moura MB, Thorne SH, Shuai Y, Anderson CJ, White AG, Lokshin A, Lee J, Singh SV. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown. Breast Cancer Research and Treatment. PMID 27097807 DOI: 10.1007/S10549-016-3795-Y |
0.341 |
|
| 2016 |
Linkov F, Goughnour S, Edwards RP, Lokshin A, Ramanathan R, Hamad GG, Bovbjerg DH. Disparities in the ameliorative effects of bariatric surgery on endometrial cancer risk biomarkers. Journal of Clinical Oncology. 34: e13038-e13038. DOI: 10.1200/Jco.2016.34.15_Suppl.E13038 |
0.362 |
|
| 2015 |
Goufman EI, Iakovlev VN, Tikhonova NB, Lokshin AE. Quantification of autoantibodies to plasminogen in plasma of patients with cancer. Cancer Biomarkers : Section a of Disease Markers. 15: 281-7. PMID 25769452 DOI: 10.3233/Cbm-150469 |
0.423 |
|
| 2015 |
Mirus JE, Zhang Y, Li CI, Lokshin AE, Prentice RL, Hingorani SR, Lampe PD. Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1764-71. PMID 25589628 DOI: 10.1158/1078-0432.Ccr-13-3474 |
0.44 |
|
| 2015 |
Sadot E, Basturk O, Klimstra DS, Gönen M, Lokshin A, Do RK, D?Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ. Tumor-Associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-Risk Disease. Annals of Surgery. PMID 25563865 DOI: 10.1097/Sla.0000000000001044 |
0.336 |
|
| 2015 |
Nolen BM, Lomakin A, Marrangoni A, Velikokhatnaya L, Prosser D, Lokshin AE. Urinary protein biomarkers in the early detection of lung cancer. Cancer Prevention Research (Philadelphia, Pa.). 8: 111-9. PMID 25416410 DOI: 10.1158/1940-6207.Capr-14-0210 |
0.761 |
|
| 2015 |
Skates SJ, Anderson KS, Liu T, Kulasingam V, Rabideau D, Wu C, Gillette M, Godwin AK, Urban N, Lokshin A, Marks J, Diamandis E, Zhang Z, Srivastava S, Kagan J, et al. Abstract 1570: Early Detection Research Network (EDRN) validation of circulating ovarian cancer biomarkers Cancer Research. 75: 1570-1570. DOI: 10.1158/1538-7445.Am2015-1570 |
0.444 |
|
| 2014 |
Nolen BM, Breen EC, Bream JH, Jenkins FJ, Kingsley LA, Rinaldo CR, Lokshin AE. Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma. Plos One. 9: e99144. PMID 24922518 DOI: 10.1371/Journal.Pone.0099144 |
0.676 |
|
| 2014 |
Geskin LJ, Akilov OE, Lin Y, Lokshin AE. Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma. Experimental Dermatology. 23: 598-600. PMID 24862743 DOI: 10.1111/Exd.12455 |
0.361 |
|
| 2014 |
Nolen BM, Brand RE, Prosser D, Velikokhatnaya L, Allen PJ, Zeh HJ, Grizzle WE, Huang Y, Lomakin A, Lokshin AE. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. Plos One. 9: e94928. PMID 24747429 DOI: 10.1371/Journal.Pone.0094928 |
0.763 |
|
| 2014 |
Wen Y, Zand B, Ozpolat B, Szczepanski MJ, Lu C, Yuca E, Carroll AR, Alpay N, Bartholomeusz C, Tekedereli I, Kang Y, Rupaimoole R, Pecot CV, Dalton HJ, Hernandez A, ... Lokshin A, et al. Antagonism of tumoral prolactin receptor promotes autophagy-related cell death. Cell Reports. 7: 488-500. PMID 24703838 DOI: 10.1016/J.Celrep.2014.03.009 |
0.383 |
|
| 2014 |
Linkov F, Burke LE, Komaroff M, Edwards RP, Lokshin A, Styn MA, Tseytlin E, Freese KE, Bovbjerg DH. An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research. Gynecologic Oncology. 133: 67-72. PMID 24462731 DOI: 10.1016/J.Ygyno.2014.01.019 |
0.318 |
|
| 2014 |
Nolen BM, Grizzle W, Brand R, Lokshin AE. Abstract 295: Urine and serum biomarkers of pancreatic cancer Cancer Research. 74: 295-295. DOI: 10.1158/1538-7445.Am2014-295 |
0.764 |
|
| 2013 |
Nolen BM, Orlichenko LS, Marrangoni A, Velikokhatnaya L, Prosser D, Grizzle WE, Ho K, Jenkins FJ, Bovbjerg DH, Lokshin AE. An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors. Plos One. 8: e63368. PMID 23723977 DOI: 10.1371/Journal.Pone.0063368 |
0.723 |
|
| 2013 |
Nolen BM, Lokshin AE. Biomarker testing for ovarian cancer: clinical utility of multiplex assays. Molecular Diagnosis & Therapy. 17: 139-46. PMID 23552992 DOI: 10.1007/S40291-013-0027-6 |
0.768 |
|
| 2013 |
Clendenen TV, Arslan AA, Lokshin AE, Liu M, Lundin E, Koenig KL, Berrino F, Hallmans G, Idahl A, Krogh V, Lukanova A, Marrangoni A, Muti P, Nolen BM, Ohlson N, et al. Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. 24: 741-8. PMID 23378139 DOI: 10.1007/S10552-013-0156-6 |
0.74 |
|
| 2013 |
Linkov FY, Komaroff M, Edwards R, Lokshin A, Styn M, Bovbjerg D, Burke L. Abstract 2521: Associations between changes in circulating inflammatory biomarkers and reduced BMI achieved in SMART and PREFER behavioral weight loss interventions. Cancer Research. 73: 2521-2521. DOI: 10.1158/1538-7445.Am2013-2521 |
0.327 |
|
| 2012 |
Bast RC, Skates S, Lokshin A, Moore RG. Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 22: S5-8. PMID 22543921 DOI: 10.1097/Igc.0B013E318251C97D |
0.378 |
|
| 2012 |
Lokshin AE. The quest for ovarian cancer screening biomarkers: are we on the right road? International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 22: S35-40. PMID 22543919 DOI: 10.1097/Igc.0B013E318251Ccaa |
0.486 |
|
| 2012 |
Menon U, Kalsi J, Jacobs I, Manchanda R, Beller U, Mould T, Skates S, Lokshin A. International Conference on Ovarian Cancer Screening: 29th-30th November 2011, Royal College of Physicians, London. Foreword. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 22: S1. PMID 22543910 DOI: 10.1097/Igc.0B013E3182557E41 |
0.357 |
|
| 2012 |
Nolen BM, Lokshin AE. Multianalyte assay systems in the differential diagnosis of ovarian cancer. Expert Opinion On Medical Diagnostics. 6: 131-138. PMID 22468148 DOI: 10.1517/17530059.2012.661711 |
0.731 |
|
| 2012 |
Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, Siegfried JM. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 698-708. PMID 22425918 DOI: 10.1097/Jto.0B013E31824Ab6B0 |
0.412 |
|
| 2012 |
Linkov F, Maxwell GL, Felix AS, Lin Y, Lenzner D, Bovbjerg DH, Lokshin A, Hennon M, Jakicic JM, Goodpaster BH, DeLany JP. Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction. Gynecologic Oncology. 125: 114-9. PMID 22198242 DOI: 10.1016/J.Ygyno.2011.12.439 |
0.422 |
|
| 2012 |
Nolen BM, Lokshin AE. Protein biomarkers of ovarian cancer: the forest and the trees. Future Oncology (London, England). 8: 55-71. PMID 22149035 DOI: 10.2217/Fon.11.135 |
0.788 |
|
| 2012 |
Nolen BM, Lomakin A, Bast R, Lu K, Marrangoni A, Lokshin AE. Abstract 3573: Urine and serum biomarkers as early detection tools for ovarian cancer Cancer Research. 72: 3573-3573. DOI: 10.1158/1538-7445.Am2012-3573 |
0.794 |
|
| 2011 |
Nolen BM, Langmead CJ, Choi S, Lomakin A, Marrangoni A, Bigbee WL, Weissfeld JL, Wilson DO, Dacic S, Siegfried JM, Lokshin AE. Serum biomarker profiles as diagnostic tools in lung cancer. Cancer Biomarkers : Section a of Disease Markers. 10: 3-12. PMID 22297547 DOI: 10.3233/Cbm-2012-0229 |
0.734 |
|
| 2011 |
Clendenen TV, Koenig KL, Arslan AA, Lukanova A, Berrino F, Gu Y, Hallmans G, Idahl A, Krogh V, Lokshin AE, Lundin E, Muti P, Marrangoni A, Nolen BM, Ohlson N, et al. Factors associated with inflammation markers, a cross-sectional analysis. Cytokine. 56: 769-78. PMID 22015105 DOI: 10.1016/J.Cyto.2011.09.013 |
0.702 |
|
| 2011 |
Nolen BM, Lokshin AE. -The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid. The International Journal of Biological Markers. 26: 141-52. PMID 21928247 DOI: 10.5301/Jbm.2011.8613 |
0.779 |
|
| 2011 |
Clendenen TV, Lundin E, Zeleniuch-Jacquotte A, Koenig KL, Berrino F, Lukanova A, Lokshin AE, Idahl A, Ohlson N, Hallmans G, Krogh V, Sieri S, Muti P, Marrangoni A, Nolen BM, et al. Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 799-810. PMID 21467242 DOI: 10.1158/1055-9965.Epi-10-1180 |
0.705 |
|
| 2011 |
Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, et al. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prevention Research (Philadelphia, Pa.). 4: 375-83. PMID 21372037 DOI: 10.1158/1940-6207.Capr-10-0193 |
0.458 |
|
| 2011 |
Cramer DW, Bast RC, Berg CD, Diamandis EP, Godwin AK, Hartge P, Lokshin AE, Lu KH, McIntosh MW, Mor G, Patriotis C, Pinsky PF, Thornquist MD, Scholler N, Skates SJ, et al. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prevention Research (Philadelphia, Pa.). 4: 365-74. PMID 21372036 DOI: 10.1158/1940-6207.Capr-10-0195 |
0.461 |
|
| 2011 |
Brand RE, Nolen BM, Zeh HJ, Allen PJ, Eloubeidi MA, Goldberg M, Elton E, Arnoletti JP, Christein JD, Vickers SM, Langmead CJ, Landsittel DP, Whitcomb DC, Grizzle WE, Lokshin AE. Serum biomarker panels for the detection of pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 805-16. PMID 21325298 DOI: 10.1158/1078-0432.Ccr-10-0248 |
0.756 |
|
| 2011 |
Linkov F, Bovbjerg DH, Goodpaster B, Lokshin A, Lenzner D, Lin Y, Felix A, Maxwell G, Delany J. Abstract A16: Longitudinal evaluation of cancer-associated biomarkers before and after weight loss: Implications for cancer risk reduction Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A16 |
0.43 |
|
| 2011 |
Levina VV, Marrangoni A, Gorelik E, Edwards R, Lokshin A. Abstract 3408: Ovarian cancer stem cell cytokine microenvironment Cancer Research. 71: 3408-3408. DOI: 10.1158/1538-7445.Am2011-3408 |
0.467 |
|
| 2011 |
Nolen BM, Lomakin A, Grizzle WE, Jhala N, Eloubeidi MA, Christein JD, Arnoletti JP, Oelschlager DK, Vickers SM, Lokshin AE. Abstract 3181: The combined use of urine and serum biomarkers in early detection strategies for pancreatic cancer Cancer Research. 71: 3181-3181. DOI: 10.1158/1538-7445.Am2011-3181 |
0.769 |
|
| 2010 |
Dogan S, Rogozina OP, Lokshin AE, Grande JP, Cleary MP. Effects of chronic vs. intermittent calorie restriction on mammary tumor incidence and serum adiponectin and leptin levels in MMTV-TGF-α mice at different ages. Oncology Letters. 1: 167-176. PMID 22966277 DOI: 10.3892/Ol_00000031 |
0.32 |
|
| 2010 |
Nolen BM, Lokshin AE. Screening for ovarian cancer: old tools, new lessons. Cancer Biomarkers : Section a of Disease Markers. 8: 177-86. PMID 22045352 DOI: 10.3233/Cbm-2011-0210 |
0.776 |
|
| 2010 |
Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, Marrangoni AM, Nolen BM, Ohlson N, Zeleniuch-Jacquotte A, Lundin E. Temporal reliability of cytokines and growth factors in EDTA plasma. Bmc Research Notes. 3: 302. PMID 21073739 DOI: 10.1186/1756-0500-3-302 |
0.704 |
|
| 2010 |
Nolen BM, Lokshin AE. Autoantibodies for cancer detection: still cause for excitement? Cancer Biomarkers : Section a of Disease Markers. 6: 229-45. PMID 20938084 DOI: 10.3233/Cbm-2009-0137 |
0.765 |
|
| 2010 |
Gu Y, Shore RE, Arslan AA, Koenig KL, Liu M, Ibrahim S, Lokshin AE, Zeleniuch-Jacquotte A. Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes & Control : Ccc. 21: 1323-33. PMID 20373009 DOI: 10.1007/S10552-010-9560-3 |
0.314 |
|
| 2010 |
Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC, Lokshin AE. Development of a multimarker assay for early detection of ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2159-66. PMID 20368574 DOI: 10.1200/Jco.2008.19.2484 |
0.762 |
|
| 2010 |
Nolen B, Velikokhatnaya L, Marrangoni A, De Geest K, Lomakin A, Bast RC, Lokshin A. Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecologic Oncology. 117: 440-5. PMID 20334903 DOI: 10.1016/J.Ygyno.2010.02.005 |
0.705 |
|
| 2010 |
Gorelik E, Lokshin A, Levina V. Lung cancer stem cells as a target for therapy. Anti-Cancer Agents in Medicinal Chemistry. 10: 164-71. PMID 20184538 DOI: 10.2174/187152010790909308 |
0.412 |
|
| 2010 |
Nolen BM, Lokshin AE. Targeting CCL11 in the treatment of ovarian cancer. Expert Opinion On Therapeutic Targets. 14: 157-67. PMID 20055715 DOI: 10.1517/14728220903512983 |
0.751 |
|
| 2010 |
Nolen B, Lomakin A, Bigbee WL, Siegfried J, Lokshin A. Serum biomarkers for early detection of lung cancer. Journal of Clinical Oncology. 28: e21057-e21057. DOI: 10.1200/Jco.2010.28.15_Suppl.E21057 |
0.757 |
|
| 2010 |
Bigbee WL, Gopalakrishnan V, Dacic S, Hauskrecht M, Weissfeld JL, Wilson DO, Siegfried JM, Lokshin AE. Abstract LB-210: A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from cancer-free high-risk subjects in a CT-screened cohort Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-210 |
0.454 |
|
| 2010 |
Nolen BM, Lomakin A, Bast R, Lu K, Grizzle WE, Jhala NC, Eloubeidi MA, Christein JD, Arnoletti JP, Oelschlager DK, Vickers SM, Marrangoni A, Lokshin A. Abstract 4567: Urine biomarkers outperform serum biomarkers in the diagnosis of various human cancers Cancer Research. 70: 4567-4567. DOI: 10.1158/1538-7445.Am10-4567 |
0.787 |
|
| 2010 |
Levina VV, Marrangoni A, Wang T, Parikh S, Su Y, Herberman R, Lokshin A, Gorelik E. Abstract 4272: Elimination of human lung cancer stem cells through targeting of the SCF-c-kit autocrine signaling loop Cancer Research. 70: 4272-4272. DOI: 10.1158/1538-7445.Am10-4272 |
0.393 |
|
| 2009 |
Levina V, Marrangoni A, Wang T, Parikh S, Su Y, Herberman R, Lokshin A, Gorelik E. Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Research. 70: 338-46. PMID 20028869 DOI: 10.1158/0008-5472.Can-09-1102 |
0.355 |
|
| 2009 |
Allen PJ, Qin LX, Tang L, Klimstra D, Brennan MF, Lokshin A. Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm. Annals of Surgery. 250: 754-60. PMID 19806054 DOI: 10.1097/Sla.0B013E3181Bd7F20 |
0.306 |
|
| 2009 |
Levina VV, Nolen B, Su Y, Godwin AK, Fishman D, Liu J, Mor G, Maxwell LG, Herberman RB, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE. Biological significance of prolactin in gynecologic cancers. Cancer Research. 69: 5226-33. PMID 19491263 DOI: 10.1158/0008-5472.Can-08-4652 |
0.751 |
|
| 2009 |
Jesneck JL, Mukherjee S, Yurkovetsky Z, Clyde M, Marks JR, Lokshin AE, Lo JY. Do serum biomarkers really measure breast cancer? Bmc Cancer. 9: 164. PMID 19476629 DOI: 10.1186/1471-2407-9-164 |
0.321 |
|
| 2009 |
Linkov F, Yurkovetsky Z, Lokshin A. Hormones as biomarkers: practical guide to utilizing luminex technologies for biomarker research. Methods in Molecular Biology (Clifton, N.J.). 520: 129-41. PMID 19381951 DOI: 10.1007/978-1-60327-811-9_9 |
0.406 |
|
| 2009 |
Levina V, Nolen BM, Marrangoni AM, Cheng P, Marks JR, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE. Role of eotaxin-1 signaling in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2647-56. PMID 19351767 DOI: 10.1158/1078-0432.Ccr-08-2024 |
0.757 |
|
| 2009 |
Nolen B, Winans M, Marrangoni A, Lokshin A. Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay. Journal of Immunological Methods. 344: 116-20. PMID 19348809 DOI: 10.1016/J.Jim.2009.03.017 |
0.731 |
|
| 2009 |
Linkov F, Gu Y, Arslan AA, Liu M, Shore RE, Velikokhatnaya L, Koenig KL, Toniolo P, Marrangoni A, Yurkovetsky Z, Zeleniuch-Jacquotte A, Lokshin AE. Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. European Cytokine Network. 20: 21-6. PMID 19318317 DOI: 10.1684/Ecn.2009.0146 |
0.446 |
|
| 2009 |
Bonorden MJL, Rogozina OP, Kluczny CM, Grossmann ME, Grambsch PL, Grande JP, Perkins S, Lokshin A, Cleary MP. Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice Nutrition and Cancer. 61: 265-275. PMID 19235043 DOI: 10.1080/01635580802419798 |
0.303 |
|
| 2009 |
Gu Y, Zeleniuch-Jacquotte A, Linkov F, Koenig KL, Liu M, Velikokhatnaya L, Shore RE, Marrangoni A, Toniolo P, Lokshin AE, Arslan AA. Reproducibility of serum cytokines and growth factors. Cytokine. 45: 44-9. PMID 19058974 DOI: 10.1016/J.Cyto.2008.10.014 |
0.39 |
|
| 2009 |
Berger RP, Ta'asan S, Rand A, Lokshin A, Kochanek P. Multiplex assessment of serum biomarker concentrations in well-appearing children with inflicted traumatic brain injury. Pediatric Research. 65: 97-102. PMID 18787505 DOI: 10.1203/Pdr.0B013E31818C7E27 |
0.322 |
|
| 2009 |
Parikh S, Levina V, Wang T, Gibson M, Lokshin A. Radioresistance of Non-small Cell Lung Cancer Stem Cells International Journal of Radiation Oncology*Biology*Physics. 75: S542-S543. DOI: 10.1016/J.Ijrobp.2009.07.1240 |
0.341 |
|
| 2008 |
Linkov F, Yurkovetsky Z, Taioli E, Havrilesky LJ, Maxwell GL, Lokshin A. Endometrial cancer: multiplexed Luminex approaches for early detection. Expert Opinion On Medical Diagnostics. 2: 527-37. PMID 23495741 DOI: 10.1517/17530059.2.5.527 |
0.47 |
|
| 2008 |
Linkov F, Ferris RL, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Gooding W, Nolan B, Winans M, Siegel ER, Lokshin A, Stack BC. Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases. Proteomics. Clinical Applications. 2: 1575-1585. PMID 19234619 DOI: 10.1002/Prca.200780095 |
0.4 |
|
| 2008 |
Nolen B, Marrangoni A, Velikokhatnaya L, Prosser D, Winans M, Gorelik E, Lokshin A. A serum based analysis of ovarian epithelial tumorigenesis. Gynecologic Oncology. 112: 47-54. PMID 19007974 DOI: 10.1016/J.Ygyno.2008.09.043 |
0.732 |
|
| 2008 |
Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: Cytokine network, tumorigenic and metastatic properties Plos One. 3. PMID 18728788 DOI: 10.1371/Journal.Pone.0003077 |
0.385 |
|
| 2008 |
Levina V, Su Y, Nolen B, Liu X, Gordin Y, Lee M, Lokshin A, Gorelik E. Chemotherapeutic drugs and human tumor cells cytokine network. International Journal of Cancer. 123: 2031-40. PMID 18697197 DOI: 10.1002/Ijc.23732 |
0.706 |
|
| 2008 |
Kilic A, Schuchert MJ, Luketich JD, Landreneau RJ, Lokshin AE, Bigbee WL, El-Hefnawy T. Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum. The Journal of Thoracic and Cardiovascular Surgery. 136: 199-204. PMID 18603076 DOI: 10.1016/J.Jtcvs.2008.01.012 |
0.47 |
|
| 2008 |
Linkov F, Edwards R, Balk J, Yurkovetsky Z, Stadterman B, Lokshin A, Taioli E. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. European Journal of Cancer (Oxford, England : 1990). 44: 1632-44. PMID 18514507 DOI: 10.1016/J.Ejca.2008.05.001 |
0.422 |
|
| 2008 |
Nolen BM, Marks JR, Ta'san S, Rand A, Luong TM, Wang Y, Blackwell K, Lokshin AE. Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. Breast Cancer Research : Bcr. 10: R45. PMID 18474099 DOI: 10.1186/Bcr2096 |
0.736 |
|
| 2008 |
Parekh DJ, Schraudenbach PT, Ankerst DP, Lokshin AE, Baillargeon J, Higgins B, Platz EA, Troyer DA, Hernandez J, Leach R, Thompson IM. A CASE-CONTROL STUDY OF FIFTY-FOUR BIOMARKERS OF PROSTATE CANCER Journal of Urology. 179: 605-605. DOI: 10.1016/S0022-5347(08)61772-3 |
0.374 |
|
| 2007 |
Linkov F, Stack B, Yurkovetsky Z, Poveda S, Lokshin A, Ferris RL. Head and neck squamous and thyroid carcinomas: multiplexed Luminex approaches for early detection. Expert Opinion On Medical Diagnostics. 1: 129-36. PMID 23489275 DOI: 10.1517/17530059.1.1.129 |
0.443 |
|
| 2007 |
Parekh DJ, Ankerst DP, Baillargeon J, Higgins B, Platz EA, Troyer D, Hernandez J, Leach RJ, Lokshin A, Thompson IM. Assessment of 54 biomarkers for biopsy-detectable prostate cancer Cancer Epidemiology Biomarkers and Prevention. 16: 1966-1972. PMID 17932343 DOI: 10.1158/1055-9965.Epi-07-0302 |
0.421 |
|
| 2007 |
Zhong H, Han B, Tourkova IL, Lokshin A, Rosenbloom A, Shurin MR, Shurin GV. Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5455-62. PMID 17875775 DOI: 10.1158/1078-0432.Ccr-07-0517 |
0.307 |
|
| 2007 |
Shurin GV, Yurkovetsky ZR, Chatta GS, Tourkova IL, Shurin MR, Lokshin AE. Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine. 39: 123-9. PMID 17689975 DOI: 10.1016/J.Cyto.2007.06.006 |
0.31 |
|
| 2007 |
Yurkovetsky Z, Ta'asan S, Skates S, Rand A, Lomakin A, Linkov F, Marrangoni A, Velikokhatnaya L, Winans M, Gorelik E, Maxwell GL, Lu K, Lokshin A. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. Gynecologic Oncology. 107: 58-65. PMID 17659325 DOI: 10.1016/J.Ygyno.2007.05.041 |
0.486 |
|
| 2007 |
Linkov F, Yurkovetsky Z, Lokshin A. Biomarker approaches to the development of cancer screening tests: can cancer blood tests become a routine health check-up? Future Oncology (London, England). 3: 295-8. PMID 17547524 DOI: 10.2217/14796694.3.3.295 |
0.493 |
|
| 2007 |
Pappas S, Federle MP, Lokshin AE, Zeh HJ. Early detection and staging of adenocarcinoma of the pancreas. Gastroenterology Clinics of North America. 36: 413-29, x. PMID 17533087 DOI: 10.1016/J.Gtc.2007.03.013 |
0.471 |
|
| 2007 |
Yurkovetsky ZR, Kirkwood JM, Edington HD, Marrangoni AM, Velikokhatnaya L, Winans MT, Gorelik E, Lokshin AE. Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2422-8. PMID 17438101 DOI: 10.1158/1078-0432.Ccr-06-1805 |
0.32 |
|
| 2007 |
Bast RC, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, Lu K, Lu Z, Badgwell D, Mills GB, Skates S, Zhang Z, Chan D, Lokshin A, Yu Y. Prevention and early detection of ovarian cancer: mission impossible? Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrã¨S Dans Les Recherches Sur Le Cancer. 174: 91-100. PMID 17302189 DOI: 10.1007/978-3-540-37696-5_9 |
0.427 |
|
| 2007 |
Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, Winans M, Bigbee W, Siegfried J, Lokshin A, Ferris RL. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 102-7. PMID 17220337 DOI: 10.1158/1055-9965.Epi-06-0602 |
0.748 |
|
| 2006 |
Yurkovetsky ZR, Linkov FY, E Malehorn D, Lokshin AE. Multiple biomarker panels for early detection of ovarian cancer. Future Oncology (London, England). 2: 733-41. PMID 17155900 DOI: 10.2217/14796694.2.6.733 |
0.4 |
|
| 2006 |
Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM. Obesity, adipokines, and prostate cancer in a prospective population-based study Cancer Epidemiology Biomarkers and Prevention. 15: 1331-1335. PMID 16835332 DOI: 10.1158/1055-9965.Epi-06-0082 |
0.35 |
|
| 2006 |
Lokshin AE, Winans M, Landsittel D, Marrangoni AM, Velikokhatnaya L, Modugno F, Nolen BM, Gorelik E. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecologic Oncology. 102: 244-51. PMID 16434085 DOI: 10.1016/J.Ygyno.2005.12.011 |
0.764 |
|
| 2006 |
Feng R, Lokshin A, Gorelik E, Lentzsch S. A Novel Multiplex Drug Screening Assay for Identification of Potential Compounds with Anti-Myeloma Activity from a Library of 1120 Drugs. Blood. 108: 3403-3403. DOI: 10.1182/Blood.V108.11.3403.3403 |
0.3 |
|
| 2006 |
Ziegler JA, Lokshin A, Lentzsch S, Agha M, Arnold R, Mapara MY. Chemokine Profiling in Patients with Graft Versus Host Disease (GVHD) Following Allogeneic Blood Stem Cell Transplantation. Blood. 108: 2877-2877. DOI: 10.1182/Blood.V108.11.2877.2877 |
0.327 |
|
| 2005 |
Sun M, Sun M, Lyons-Weiler J, Lokshin AE, Modugno F, Marks J, Bigbee WL. Serum proteomic profiling distinguishes estrogen receptor (ER) positive and ER negative breast cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 578. PMID 27946485 DOI: 10.1200/Jco.2005.23.16_Suppl.578 |
0.391 |
|
| 2005 |
Zeh HJ, Winikoff S, Landsittel DP, Gorelik E, Marrangoni AM, Velikokhatnaya L, Winans MT, Lee K, Moser A, Bartlett D, Lotze MT, Siegfried JM, Whitcomb D, Papacristou G, Slivka A, ... ... Lokshin AE, et al. Multianalyte profiling of serum cytokines for detection of pancreatic cancer. Cancer Biomarkers : Section a of Disease Markers. 1: 259-69. PMID 17192050 DOI: 10.3233/Cbm-2005-1601 |
0.494 |
|
| 2005 |
Bast RC, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, Lokshin A, Menon U, Jacobs I, Lu K. New tumor markers: CA125 and beyond. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 15: 274-81. PMID 16343244 DOI: 10.1111/J.1525-1438.2005.00441.X |
0.472 |
|
| 2005 |
Huang X, Raskovalova T, Lokshin A, Krasinskas A, Devlin J, Watkins S, Wolf SF, Gorelik E. Combined antiangiogenic and immune therapy of prostate cancer. Angiogenesis. 8: 13-23. PMID 16132614 DOI: 10.1007/S10456-005-2893-Y |
0.315 |
|
| 2005 |
Gorelik E, Landsittel DP, Marrangoni AM, Modugno F, Velikokhatnaya L, Winans MT, Bigbee WL, Herberman RB, Lokshin AE. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 981-7. PMID 15824174 DOI: 10.1158/1055-9965.Epi-04-0404 |
0.497 |
|
| 2005 |
FERRIS R, LOKSHIN A, STACKJR B. Serum Cytokine Profiling for Discovery of Novel Markers of Thyroid Malignancy Otolaryngology - Head and Neck Surgery. 133: P96-P96. DOI: 10.1016/J.Otohns.2005.05.203 |
0.339 |
|
| 2004 |
Gorelik E, Edwards RP, Feng X, Marrangoni AM, Grandis JR, Drenning SD, Velikokhatnaya L, Kwon JA, Lokshin AE. IL-12 receptor-mediated upregulation of FasL in human ovarian carcinoma cells International Journal of Cancer. 112: 620-627. PMID 15382042 DOI: 10.1002/Ijc.20482 |
0.341 |
|
| 2004 |
Winikoff S, Lokshin A, Landsittel D, Lee KL, Moser AJ, Schraut WH, Lotze MT, bartlett DL, Zeh HJ. A novel method of pancreatic cancer detection by simultaneous analysis of multiple serum markers Annals of Surgical Oncology. 11: S114-S114. DOI: 10.1007/Bf02524171 |
0.451 |
|
| 1996 |
Lokshin A, Levitt ML. Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines. Journal of Cellular Biochemistry. Supplement. 24: 186-97. PMID 8806101 DOI: 10.1002/Jcb.240630514 |
0.377 |
|
| 1994 |
Nair S, Mayotte J, Lokshin A, Levitt M. Induction of squamous differentiation by interferon beta in a human non-small-cell lung cancer cell line. Journal of the National Cancer Institute. 86: 378-83. PMID 7905929 DOI: 10.1093/Jnci/86.5.378 |
0.372 |
|
| Show low-probability matches. |